指南与共识消化道肿瘤放疗放疗物理与技术

ESTRO IORT任务组/ACROP建议:不可切除胰腺癌术中放疗

ESTRO IORT Task Force/ACROP recommendations for intraoperative radiation therapy in unresected pancreatic cancer.
指南 / 共识 · Radiother Oncol · 2020-04-08

该建议由ESTRO IORT任务组/ACROP制定,针对不可切除胰腺癌的术中电子放疗(IOERT)给出操作推荐。不可切除患者接受外照射放疗联合IOERT推量后,3年总生存率6%、5年以上3%。IOERT剂量沉积精准、正常组织保护好,可与系统治疗和外科进展整合,NCCN指南推荐用于切缘近或残留病变。

要点

  • 不可切除胰腺癌可考虑外照射联合IOERT推量,长期生存罕见但存在。
  • IOERT剂量沉积精准、正常组织保护好,证据成熟但官方证据级别低。
  • NCCN指南推荐IOERT用于切缘近或残留病变。

核心结论

  • IOERT是不可切除胰腺癌多模式治疗中可接受的精准推量手段,可与系统治疗和外科进展整合。

研究设计与样本

  • ESTRO IORT任务组/ACROP制定针对不可切除胰腺癌实施IOERT的建议。

主要发现

  • 不可切除患者接受外照射放疗联合IOERT推量后,3年总生存率6%,5年以上3%。
  • 提高放疗剂量改善局部控制,对疾病播散倾向较低患者的生存有影响。
  • IOERT剂量沉积精准、正常组织保护好,结果成熟可重复但官方证据级别低。

关键数值与推荐

  • NCCN指南推荐IOERT用于切缘近或残留病变。
  • 不可切除疾病可从系统治疗背景下的剂量递增化放疗策略中获益。
  • 延长术前治疗可作为筛选隐匿耐药转移患者的过滤器。

临床怎么用

  • 对不可切除胰腺癌,在系统治疗和潜在根治手术背景下可整合IOERT推量。
  • 切缘近或残留病变患者可按NCCN推荐考虑IOERT。

局限性

  • IOERT结果的官方证据级别低。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Radiation therapy (RT) is a valuable component of multimodal treatment for localized pancreatic cancer. Intraoperative radiation therapy (IORT) is a very precise sub-component of RT that can intensify the irradiation effect for cancer involving an anatomically well-defined volume, generally delivered with electrons (IOERT). Unresectable disease categories benefit from dose-escalated chemoradiation strategies in the context of active systemic therapy and potential radical surgery. Prolonged preoperative treatment may act as a filter for selecting patients with occult resistant metastatic disease. Long-term survivors were observed among unresected patients treated with external beam RT and an IOERT boost (OS 6% at 3 years; 3% >5 years). Improvement of local control through higher RT doses has an impact on the survival of patients with a lower tendency towards disease spread. IOERT is a well-accepted asset in the clinical scenario (maturity and reproducibility of results, albeit of low official level of evidence) and extremely accurate in terms of dose-deposit characteristics and normal tissue sparing. It is a technique that can be integrated with systemic therapy and surgical progress. International guidelines (National Comprehensive Cancer Network or NCCN guidelines) currently recommend the use of IOERT in cases of close surgical margins and residual disease. We report the ESTRO/ACROP recommendations for performing IOERT in unresected pancreatic cancer.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Calvo FA, Krengli M, Asencio JM, et al. ESTRO IORT Task Force/ACROP recommendations for intraoperative radiation therapy in unresected pancreatic cancer. Radiother Oncol. 2020. PMID: 32339779. doi:10.1016/j.radonc.2020.03.040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。